Enjoy complimentary customisation on priority with our Enterprise License!
The global viral vectors market size is estimated to grow by USD 1.17 billion, at a CAGR of 7.02% between 2023 and 2028. The market growth and forecasting report also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
Recent discoveries have improved the understanding of viral molecular biology and genetics, which has enabled the use of viruses as vaccine platforms and as potential agents for the treatment of cancer and infectious diseases, such as HIV. Viral vectors are considered a feasible option to deliver vaccine antigens and to specifically target and kill disease-causing agents due to their ability to effectively induce both humoral and cell-mediated immune responses. Recombinant viral vector vaccines have the potential to be used as therapeutic vaccines, as they enable an intracellular antigen expression and induce a strong cytotoxic T lymphocyte response, which results in the elimination of virus-infected cells. The advantages have led to an increase in their use in the development of vaccines. Thus, the increasing use of viral vectors for the development of vaccines to treat various diseases will drive the growth of the market during the forecast period.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.